Atacicept Autoinjector Combination, Atacicept
VT-001-0060
Phase 2 small_molecule active
Quick answer
Atacicept Autoinjector Combination, Atacicept for Multiple Autoimmune Glomerular Diseases is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Multiple Autoimmune Glomerular Diseases
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active